Probiotics
Microbiome, live cultures and functional health.
Latest Probiotics news
60,000 Years of Food Knowledge: Traditional Aboriginal Diets and Nutrition
Read at News-Medical →5 Fruits with More Gut-Health Benefits Than Kale
Read at EatingWell →Gut Antibody Pathway Linked to Bacterial Overgrowth and Obesity in Mice
Read at Dr. Axe →Vegan diets have a surprising effect on gut bacteria, study reveals
Read at Earth.com →Fiber-Gut Bacteria Pathway Aids Healing in Mice, Not in Colitis Trial
Read at Dr. Axe →Gut-testing services gain ground among health-conscious people
Read at Japan Today →From the knowledge base
StockWatch: Gene Editing Shares Jump on ESGCT Data, FDA Draft Guidance
Shares of gene editing therapy companies mostly surged this past week on two growth catalysts: Data readouts at the European Society of Gene and Cell Therapy’s 33rd ESGCT Annual Congress, and the FDA's new draft guidance for personalized gene therapies.
How the NEXTY Awards open doors to valuable food service partnerships
Corporate food service providers offer bulk purchases, direct feedback and exposure to thousands of consumers. Here's how the NEXTY Awards can help you break in.
Anthropic’s one-person biotech buy; Jake Van Naarden’s dealmaking strategy; and more
Hello and welcome back to a spooky Halloween edition of Endpoints Weekly! Sorry to all the candy corn lovers out there, but just noting that they’re actually made with bug secretions. The Atlantic has all ...
Opentrons Raises $40M in Series E to Expand Its Robotics, Software, Data Infrastructure
According to the company, the funds will support the next phase of its growth in enabling autonomous science in labs and biopharmaceutical companies using its AI and robotics systems.
100 Million-Cell AI-Ready Dataset with Single-Cell and Proteomic Data Created by Parse and Nomic
Parse Biosciences and Nomic Bio are partnering to create Cascade, a 100-million-cell multimodal dataset combining single-cell and proteomic data to advance AI-driven immune modeling, drug discovery, and therapeutic target identification.
Sanofi may seek higher European drug prices, not withhold launches, under Trump deal
While some of Europe’s biggest drugmakers have warned that President Donald Trump’s pricing policies could leave European patients waiting longer for new medicines, Sanofi is taking a different approach. ...